Contribute Try STAT+ Today

It’s tempting to see Haven as another casualty of entrenched interests in American medicine. But the endeavor, however ambitious, also collided with the equally unmovable aims of Amazon, whose sweeping campaign to disrupt health care began long before it formed Haven with Berkshire Hathaway and JPMorgan Chase in 2018.

Amazon beat Haven to the punch on one of its core initiatives, an effort to develop a digital product to streamline access to primary care and prescriptions for employees. Even though Amazon Care was initially confined to Amazon office workers in Seattle, its launch in September 2019 blindsided several rank-and-file employees at the startup who were struck by similarities to the product they had been building.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.